Search Results

Showing results 9751 - 9760 for 2022

A New Theranostic Tool — Diagnostics and Therapy with Radiolead | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/new-theranostic-tool-%E2%80%94-diagnostics-and-therapy-radiolead

The William D. Stubenbord Lecture sponsored by the Louis Calder Foundation | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/william-d-stubenbord-lecture-sponsored-louis-calder-foundation-0

Grant Awarded to Investigate Antifungal Therapies in Crohn’s Patients | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/grant-awarded-investigate-antifungal-therapies-crohn%E2%80%99s-patients

Graduate School Diversity Week Events | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/graduate-school-diversity-week-events-0

Graduate School Diversity Week Events | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/graduate-school-diversity-week-events-1

Meyer Cancer Center Director’s Seminar Series | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/meyer-cancer-center-director%E2%80%99s-seminar-series-8

Graduate School Diversity Week Events | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/graduate-school-diversity-week-events

A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab in Combination With Pola-R-CHP Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma | Joint Clinical Trials Office

...untreated with CD20-positive large B-cell lymphoma (LBCL), including one of the following diagnoses by 2022...

https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-iii-multicenter-randomized-open-label-study-comparing-the-efficacy-and-safety-of-glofitamab-in-combination-with-pola-r-chp-versus-pola-r-chp-in-previously-untreated-patients-with-large-b-cell-lymphoma

Epigenomics: Recording the past & predicting the future | Research | Weill Cornell Medicine

...IRB Newsletter April 2022 IRB Newsletter June 2022 IRB Newsletter March 2022 IRB Newsletter May...

https://research.weill.cornell.edu/about-us/news-updates/epigenomics-recording-past-predicting-future

System-wide transcriptome damage and tissue identity loss in COVID-19 patients. | Pathology & Laboratory Medicine

...Publication Type Journal Article Year of Publication 2022 Authors Park J, Foox J, Hether T, Danko DC...

https://pathology.weill.cornell.edu/research/publications/system-wide-transcriptome-damage-and-tissue-identity-loss-covid-19-patients

Showing results 9751 - 9760 for 2022